No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly females |
313377 |
2. Check conditionsNone |
313377 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
165 |
4. Check minimum number of eventsNone |
165 |
5. Include endpointsNone |
165 |
6. Filter based on genotype QC (FinnGen only) |
154 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Granulosa cell carcinoma of ovary
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 154 | 154 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 55.46 | 55.46 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 160
- Matched controls
- 1600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8620/3-C56.9
ICD-O-3
Adult granulosa cell tumor of ovary of ovary
+∞
231.4
160
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
176.4
135
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
105.5
156.3
85
17
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
25.3
75.0
60
37
JN4BD
NOMESCO Finland
Extensive body CT
29.4
66.3
48
23
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
27.0
64.0
48
25
B01AB10
ATC
tinzaparin; parenteral
14.4
59.5
69
80
128
Kela drug reimbursment
Cancers of female genital organs
+∞
48.4
44
*
H02AB02
ATC
dexamethasone; systemic
75.0
39.8
44
8
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
39.2
36
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
35.8
33
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
16.4
35.0
32
24
JN4AD
NOMESCO Finland
Body CT examination
13.0
33.7
36
35
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.3
33.7
44
57
JAL30
NOMESCO Finland
Omentectomy
76.7
32.7
36
6
JAL00
NOMESCO Finland
Biopsy of peritoneum
132.3
30.9
32
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
36.4
30.7
39
14
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
6.7
29.1
63
142
JEA00
NOMESCO Finland
Appendectomy
11.2
27.5
32
35
B01AB05
ATC
enoxaparin; parenteral
5.7
27.1
93
313
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
12.0
26.4
29
29
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
9.6
25.3
33
42
LCD00
NOMESCO Finland
Hysterectomy
8.3
24.6
37
56
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
10.5
24.1
29
33
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
5.5
24.0
109
450
L02BG04
ATC
letrozole; oral
51.3
22.2
26
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.1
21.7
65
190
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
21.3
20
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
21.3
20
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
21.0
21.0
31
18
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.4
20.7
27
34
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
5.5
20.6
51
126
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
20.2
19
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.2
19
*
A04AA01
ATC
ondansetron; systemic, rectal
17.2
19.6
31
22
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
19.1
18
*
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
16.5
18.7
30
22
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.9
18.0
26
14
WX402
NOMESCO Finland
General anaesthesia
4.4
17.3
59
187
HA1AA
NOMESCO Finland
X-ray mammography
8.0
17.1
25
36
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
17.0
56
172
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.6
17.0
52
151
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
17.0
16
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
17.0
16
*
ZX120
NOMESCO Finland
Intravenous
8.1
16.6
24
34
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
37.8
16.2
20
6
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
67.1
16.1
18
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.8
16.0
86
371
A04AA02
ATC
granisetron; systemic, transdermal
164.4
14.7
15
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.0
14.7
37
91
TPH07
NOMESCO Finland
Cathetrisation of artery
5.4
14.0
31
68
115
Kela drug reimbursment
Breast cancer
+∞
13.7
13
*
L02BA01
ATC
tamoxifen; oral
+∞
13.7
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.7
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
152.4
13.7
14
*
L02AB02
ATC
medroxyprogesterone; systemic
44.2
13.4
16
*
R2110
NOMESCO Finland
Giving the first information
5.2
11.9
27
60
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
11.6
11
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
11.6
11
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
11.6
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.1
11.3
84
420
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
14.5
10.4
17
13
LCA06
NOMESCO Finland
Biopsy of endometrium
3.2
9.6
47
182
A04AD12
ATC
aprepitant; systemic
+∞
9.5
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.5
9
*
D39.13
ICD-10 Finland
Uncertain growth nature of the ovarian tumor, sex chord derived
+∞
9.5
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
9.5
9
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
9.5
9
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
9.5
9
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
3.3
9.2
41
150
JAH00
NOMESCO Finland
Laparotomy
15.2
8.9
14
10
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
94.8
8.5
9
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
8.4
54
242
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
JAW96
NOMESCO Finland
Other operation on abdominal wall, peritoneum, mesentery or omentum
+∞
8.4
8
*
L03AA02
ATC
filgrastim; parenteral
+∞
8.4
8
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
47.3
7.8
9
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.6
7.7
15
17
WZC00
NOMESCO Finland
Treatment plan or consultation
2.6
7.7
68
356
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
7.3
7
*
D27.93
ICD-10 Finland
Benign ovarian tumor, sex chord stroma derived
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
D39.12
ICD-10 Finland
Granulosa cell tumor of uncertain nature in the ovary
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.6
7.0
11
8
WW500
NOMESCO Finland
Blood transfusion
14.6
7.0
11
8
121
Kela drug reimbursment
Severe hypofunction of sexual glands
8.0
6.6
14
19
N95.0
ICD-10 Finland
Postmenopausal bleeding
2.9
6.4
34
136
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
7.6
6.4
14
20
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
A04AA03
ATC
tropisetron; systemic
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
JAL23
NOMESCO Finland
Excision of local lesion of pelvic wall
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.3
6
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
6.2
26
90
LEB00
NOMESCO Finland
Biopsy of vagina
9.2
6.2
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
46
66
9.38
32.43
1.7
1.8
5.54
2.41
ug/l
0.46
32
44
115
598
4.28
16.32
3.0
2.3
—
—
estimate
—
0
0
37
92
4.93
14.49
2.5
1.3
30.33
25.39
iu/l
0.47
31
82
70
297
3.41
12.79
2.1
1.8
—
—
—
0
0
18
44
4.48
7.02
1.8
1.8
32.37
7522.77
u/l
—
6
15
10
9
11.75
5.88
1.1
2.0
—
—
—
0
0
5
0
+∞
5.23
6.0
0.0
29.78
—
u/ml
—
5
0
105
749
2.17
5.08
10.9
6.8
3.67
3.85
e9/l
0.31
91
653
77
496
2.06
4.81
2.5
1.9
2.37
2.36
mmol/l
0.22
72
444
109
816
2.05
4.30
3.6
3.6
0.00
0.02
estimate
0.50
24
149
8
15
5.55
3.23
1.0
1.1
—
—
—
0
0
66
453
1.78
3.06
2.7
3.0
—
—
—
0
0
55
360
1.80
2.98
2.3
2.8
0.35
0.43
e6/l
0.24
39
256
137
1196
2.01
2.52
20.3
14.5
13.71
13.48
%
1.13
137
1183
87
672
1.65
2.47
7.2
5.3
1.21
1.22
mmol/l
0.90
80
585
124
1058
1.76
2.34
8.3
5.3
76.91
76.31
u/l
0.08
119
979
47
319
1.67
2.16
1.7
1.7
1.08
1.08
mg/l
0.01
42
260
20
105
2.03
2.06
3.5
2.7
—
—
—
0
0
151
1400
2.40
2.01
14.4
11.3
25.11
18.49
mg/l
1.77
129
1088
60
440
1.58
2.01
3.8
3.7
0.00
0.00
estimate
-0.00
24
148
155
1458
3.02
2.00
18.7
13.5
139.93
140.02
mmol/l
0.20
155
1425
18
92
2.08
1.99
1.5
1.9
—
—
—
0
0
20
107
1.99
1.97
2.1
1.9
59.60
69.33
ml/min/173m2
—
10
45
25
147
1.83
1.88
5.2
4.2
1.06
1.06
mmol/l
0.01
19
131
10
44
2.36
1.59
1.4
1.4
—
—
—
0
0
128
1384
0.62
1.48
4.2
4.4
1.34
1.25
mmol/l
0.72
120
1287
32
218
1.58
1.43
1.8
2.6
2.11
1.11
e6/l
0.54
16
107
23
144
1.70
1.42
7.8
5.3
104.65
104.31
mmol/l
0.14
23
144
8
160
0.47
1.33
2.4
1.9
—
—
—
0
0
94
806
1.40
1.28
3.7
3.6
0.00
0.00
estimate
-0.00
24
154
149
1402
1.91
1.26
17.0
10.8
82.92
81.86
ml/min/173m2
0.29
136
1280
21
315
0.62
1.25
1.8
1.6
—
—
—
0
0
132
1210
1.52
1.19
21.2
15.5
330.71
330.54
g/l
0.09
132
1205
57
697
0.72
1.19
1.8
1.9
1.35
1.34
mmol/l
0.03
48
600
5
20
2.55
1.16
1.0
1.4
—
—
—
0
0
94
817
1.36
1.12
3.7
3.6
0.00
0.00
estimate
-0.00
25
157
141
1479
0.61
1.11
5.3
6.0
2.80
2.84
mmol/l
0.26
132
1386
49
384
1.40
1.10
1.6
1.4
—
—
—
0
0
5
22
2.31
1.04
1.0
1.1
—
—
—
0
0
12
69
1.80
0.99
11.6
7.8
0.78
0.62
%
0.64
12
69
8
144
0.53
0.99
2.3
1.8
—
—
—
0
0
0
32
0.00
0.96
0.0
1.6
—
0.87
—
0
24
134
1414
0.68
0.95
5.2
5.9
1.93
1.84
mu/l
0.23
129
1328
6
27
2.27
0.94
1.3
1.5
—
—
—
0
0
26
187
1.47
0.93
1.8
2.9
4.60
4.10
e6/l
0.08
11
76
32
415
0.71
0.92
1.4
1.3
1.70
1.38
u/ml
—
8
131
12
71
1.75
0.91
11.7
7.8
1.25
1.38
%
0.26
12
71
71
605
1.31
0.91
3.6
3.4
0.00
0.03
estimate
0.74
20
115
5
96
0.51
0.81
1.2
1.5
—
—
—
0
0
0
24
0.00
0.80
0.0
1.6
—
—
—
0
0
5
27
1.88
0.69
1.6
1.1
—
—
—
0
0
5
27
1.88
0.69
1.0
1.1
—
—
—
0
0
8
49
1.67
0.63
1.5
1.2
—
—
—
0
0
8
49
1.67
0.63
1.5
1.2
—
—
—
0
0
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
68
754
0.83
0.52
2.6
3.1
125.92
77.30
ug/l
0.65
63
710
12
84
1.46
0.51
2.5
1.3
—
—
—
0
0
141
1454
0.75
0.50
4.5
5.2
1.54
1.61
mmol/l
1.03
133
1364
50
437
1.21
0.48
2.9
3.0
0.00
0.00
estimate
-0.00
18
123
142
1462
0.74
0.48
4.7
5.3
4.86
4.88
mmol/l
0.08
135
1376
10
69
1.48
0.45
7.6
6.5
22.84
25.53
mmol/l
—
10
69
5
31
1.63
0.43
2.4
4.2
12.02
30.10
mg/l
—
5
20
5
33
1.53
0.41
5.0
2.8
8.96
6.03
pmol/l
—
5
33
59
652
0.85
0.41
1.7
2.1
88.82
102.48
pmol/l
1.51
26
305
9
66
1.39
0.39
1.9
1.6
—
—
—
0
0
45
504
0.85
0.37
3.6
4.0
10.09
5.50
mg/mmol
0.32
28
274
135
1391
0.81
0.37
4.9
6.3
38.82
38.80
mmol/mol
0.01
129
1318
140
1437
0.79
0.36
4.4
5.1
5.73
5.81
mmol/l
0.44
131
1334
12
92
1.33
0.33
1.1
1.1
—
—
—
0
0
7
55
1.29
0.30
1.4
1.4
—
—
—
0
0
121
1252
0.86
0.30
4.3
4.8
14.56
14.71
pmol/l
0.29
114
1165
8
63
1.28
0.28
2.6
2.6
26.37
25.46
mmol/l
—
8
63
15
182
0.81
0.28
5.8
5.2
—
—
—
0
0
11
88
1.27
0.23
1.3
1.5
—
—
—
0
0
10
79
1.28
0.23
1.3
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
70.01
—
0
10
0
10
0.00
0.21
0.0
1.0
—
8.90
—
0
10
0
10
0.00
0.21
0.0
6.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
1.07
—
0
6
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
41
379
1.11
0.19
2.6
3.0
824.30
790.53
ng/l
0.05
36
316
10
121
0.81
0.18
1.7
1.7
—
—
—
0
0
11
91
1.22
0.18
1.9
1.5
—
—
—
0
0
15
173
0.85
0.17
3.0
2.0
3.20
3.30
ratio
—
8
143
49
522
0.91
0.17
3.5
3.4
22.89
18.48
ng/l
0.18
36
330
34
369
0.90
0.17
1.6
1.3
14.45
35.85
iu/ml
2.38
11
120
14
121
1.17
0.15
2.1
2.9
1.58
2.23
mmol/l
0.19
14
106
38
356
1.09
0.13
3.7
3.7
1.01
1.02
kg/l
1.20
23
229
92
943
0.94
0.10
3.4
3.1
—
—
—
0
0
23
248
0.92
0.10
3.4
3.6
23.94
42.61
ng/l
0.47
18
171
5
48
1.04
0.09
1.0
1.2
0.96
0.89
g/l
—
5
48
7
68
1.03
0.08
16.7
6.9
23.16
25.01
mmol/l
—
7
68
8
74
1.09
0.07
2.6
2.4
1.17
1.17
%
—
8
74
33
346
0.94
0.07
1.4
1.3
2.09
11.70
u/ml
2.50
16
143
16
171
0.93
0.05
2.6
2.4
20.05
23.19
%
0.73
16
157
14
130
1.08
0.05
1.4
1.7
—
—
—
0
0
17
179
0.94
0.03
1.8
1.7
—
—
—
0
0
12
126
0.95
0.00
1.6
1.5
—
—
—
0
0
15
145
1.04
0.00
2.1
1.8
371.33
358.09
nmol/l
0.15
15
138
14
135
1.04
0.00
2.3
1.8
3.33
3.56
mmol/l
—
6
105
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
47.86
—
0
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
9.72
—
0
9
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.5
—
—
—
0
0
6
64
0.94
-0.00
1.5
3.1
21.40
24.48
mmol/l
—
6
64
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.0
—
888.34
—
0
8
0
8
0.00
-0.00
0.0
1.9
—
7.40
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_GRANULOSA – Granulosa cell carcinoma of ovary
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).